Multiple Myeloma: ASCO Tumor Boards

Product ID : TMM17
Price: $15.00
You will receive a link to your product from within 1 hour of purchase confirmation. Shipping charges do not apply to digital products.
E-mail to a friend



This is a case-based activity that includes discussion of two patients with multiple myeloma:


1. A 64-year-old woman with relapsed IgG kappa myeloma presents to the clinic. She originally presented with standard risk disease and was treated with RVd induction therapy. She achieved a VGPR. Treatment continued with autologous stem cell transplant with achievement of CR, following by lenalidomide maintenance for 3 years.


2. A 71-year-old man presents to clinic with lytic lesions in his axial and appendicular skeleton. He was originally diagnosed with IgA kappa multiple myeloma. FISH showed del (17p), a high-risk feature.


IMPORTANT NOTE: This course expires on May 17, 2020. Participants must complete all necessary course components by this date.


Purchase the 2017 ASCO Tumor Boards Bundle to access to all 2017 ASCO Tumor Boards for added savings. Purchased separately, these items would be $180 altogether. When bundled, you save $55.

Recommended Products